Cognito Therapeutics vs Supernus Pharmaceuticals
Cognito Therapeutics vs Supernus Pharmaceuticals, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cognito Therapeutics is on 50/100 and Supernus Pharmaceuticals on 60/100.
Where each one leads
Cognito Therapeutics
- funding raised: $213M against $17.5M
Supernus Pharmaceuticals
- our overall score: 60/100 against 50/100
- agent readiness: 41/100 against 33/100
- domain rating: 66/100 against 47/100
At a glance
| Measure | Cognito Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| What it is | Developing a novel therapeutic approach for Alzheimer's disease. | Biopharmaceutical company developing and commercializing CNS disease treatments. |
| Category | Biotechnology, Medical Devices, Neuroscience, Healthcare | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Services |
| Founded | 2011 | 2005 |
| Headquarters | Boston, USA | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cognito Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| Employees | Not published | 809 |
| Total funding | $213M | $17.5M |
| Latest round | Series C | Series A |
| Valuation | $487M | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cognito Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 50/100 | 60/100 |
| Traction | 40/100 | 56/100 |
| Team | 60/100 | 30/100 |
| Search visibility | 10/100 | 15/100 |
| Quality | 65/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | 47/100 | 66/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cognito Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Not detected |
| Frameworks | Not detected | Tailwind CSS, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
| Open source | Yes | No |
Cognito Therapeutics vs Supernus Pharmaceuticals: common questions
Which is better, Cognito Therapeutics or Supernus Pharmaceuticals?
On our 0-100 score Supernus Pharmaceuticals rates higher (60/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Cognito Therapeutics and Supernus Pharmaceuticals compare on the numbers?
Cognito Therapeutics leads on funding raised ($213M against $17.5M). Supernus Pharmaceuticals leads on our overall score (60/100 against 50/100), agent readiness (41/100 against 33/100), domain rating (66/100 against 47/100).
Read the full Cognito Therapeutics review and pricing or the Supernus Pharmaceuticals review and pricing. You can also browse other Cognito Therapeutics alternatives we track.